176 related articles for article (PubMed ID: 28266301)
1. Screening for Bowel Cancer: Increasing Participation via Personal Invitation.
Hoffmeister M; Holleczek B; Zwink N; Stock C; Stegmaier C; Brenner H
Dtsch Arztebl Int; 2017 Feb; 114(6):87-93. PubMed ID: 28266301
[TBL] [Abstract][Full Text] [Related]
2. Invitation letters increase participation in colorectal cancer screening - results from an observational study.
Zhan T; Hielscher T; Bilge A; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2017 Dec; 55(12):1307-1312. PubMed ID: 29212101
[No Abstract] [Full Text] [Related]
3. Should Screening Colonoscopy Be Offered From Age 50?
Brenner H; Zwink N; Ludwig L; Hoffmeister M
Dtsch Arztebl Int; 2017 Feb; 114(6):94-100. PubMed ID: 28266302
[TBL] [Abstract][Full Text] [Related]
4. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
[TBL] [Abstract][Full Text] [Related]
5. Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).
Pisera M; Kaminski MF; Kraszewska E; Rupinski M; Regula J
Eur J Gastroenterol Hepatol; 2016 May; 28(5):538-42. PubMed ID: 26967693
[TBL] [Abstract][Full Text] [Related]
6. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing.
Gruner LF; Hoffmeister M; Ludwig L; Meny S; Brenner H
Dtsch Arztebl Int; 2020 Jun; 117(25):423-430. PubMed ID: 32885780
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
9. Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.
Bauer A; Riemann JF; Seufferlein T; Reinshagen M; Hollerbach S; Haug U; Unverzagt S; Boese S; Ritter-Herschbach M; Jahn P; Frese T; Harris M; Landenberger M
Dtsch Arztebl Int; 2018 Oct; 115(43):715-722. PubMed ID: 30518470
[TBL] [Abstract][Full Text] [Related]
10. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
[TBL] [Abstract][Full Text] [Related]
11. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
12. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.
Tinmouth J; Llovet D; Sutradhar R; Tsiplova K; Roushani J; Lee A; Hader J; Rabeneck L; Paszat L
Prev Med; 2022 Feb; 155():106918. PubMed ID: 34953810
[TBL] [Abstract][Full Text] [Related]
13. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the personalized invitation of Czech citizens to screening programs.
Ngo O; Chloupková R; Ambrožová M; Suchánek Š; Zavoral M; Seifert B; Dvořák V; Daneš J; Skovajsová M; Dušek L; Májek O
Cas Lek Cesk; 2019; 158(3-4):147-150. PubMed ID: 31416323
[TBL] [Abstract][Full Text] [Related]
15. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
16. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
[TBL] [Abstract][Full Text] [Related]
18. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
[TBL] [Abstract][Full Text] [Related]
19. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
20. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
